Understanding Your Lab Results: What ‘Normal’ Doesn’t Mean ‘Optimal’

A 32-year-old man walks out of his doctor’s office. His testosterone came back at 310 ng/dL. The lab report says “normal.” His doctor says everything looks fine. He feels terrible. Both of those things can be true at the same time.

The lab was not wrong. The doctor was not lying. The reference range for total testosterone in adult males typically spans 264–916 ng/dL. At 310, he is inside the range. Technically, statistically, clinically — normal. But “normal” is a statistical concept, not a biological verdict. It tells you where the population falls. It does not tell you where you should be.

This disconnect — between what lab reports say and what your body is telling you — is one of the most consequential gaps in modern health management. And it is almost entirely preventable, if you know what you are looking at.

What reference ranges actually mean.

A reference range is not a prescription but a statistical summary. Most clinical reference ranges are derived by measuring a biomarker across a large sample of people, discarding the top and bottom 2.5%, and calling whatever remains “normal.” That middle 95% becomes the range printed on your lab report.

This method has obvious strengths. It is reproducible. It is standardized. It gives physicians a quick way to flag values that fall outside the expected distribution. But it also has a critical limitation: the reference population defines the range. If the population being sampled is aging, sedentary, metabolically unhealthy, or overweight, the “normal” range will reflect that. A fasting glucose of 99 mg/dL may be “normal” against a population with a 40% prediabetes prevalence. That does not make it optimal for you.^[6]

Different labs use different reference populations, different assays, and different methodologies. This is why your testosterone result from Lab A might fall within range while the same blood drawn on the same day at Lab B might not. The number did not change. The ruler did. Always use your lab’s specific reference ranges, not generic ranges from the internet.

The problem with population averages.

Consider testosterone again. The reference range of 264–916 ng/dL covers an enormous biological spread. A 25-year-old male at the peak of his hormonal output and a 75-year-old with decades of age-related decline can both fall within “normal.” Harman et al. documented that serum testosterone declines approximately 1% per year after age 30 — a slow, steady erosion that is entirely “normal” from a statistical standpoint but may be anything but optimal from a functional one.^[5]

The AUA defines testosterone deficiency as total testosterone below 300 ng/dL.^[4] The Endocrine Society uses a similar threshold, recommending evaluation for hypogonadism when total testosterone is consistently below 300 ng/dL, particularly in the presence of symptoms.^[3] But a man at 310 ng/dL — just above both cutoffs — can present with fatigue, decreased libido, reduced muscle mass, and impaired cognitive function. His labs say normal. His body disagrees.

This is not limited to hormones. Population-derived ranges face the same problem across nearly every biomarker. Vitamin D “sufficiency” is often defined as ≥20 ng/mL, yet many endocrinologists and functional medicine practitioners argue that levels between 40–60 ng/mL are associated with better outcomes. Ferritin is “normal” from roughly 20–300 ng/mL in men — a 15-fold spread that encompasses both borderline iron deficiency and iron overload, depending on context.

The lesson is not that reference ranges are useless. They are essential for identifying gross abnormalities. The lesson is that “within range” is the beginning of the conversation, not the end of it. A value at the 5th percentile and one at the 95th percentile are both “normal” — and they can represent profoundly different physiological states.

Trends beat snapshots.

A single lab draw is a photograph. Useful, but static. A snapshot of what your blood looked like at 8:14 AM on a Tuesday after you fasted for 12 hours and slept poorly because you were anxious about the draw. It does not tell you what your blood looks like on a normal Tuesday, or what it looked like three months ago, or where it is heading.

Ceriotti et al. demonstrated that serial monitoring — tracking the same biomarker in the same individual over time — detects clinically meaningful shifts that single-point comparisons against population reference ranges routinely miss.^[1] This is the concept of the reference change value (RCV): the minimum difference between two sequential measurements that represents a statistically significant change beyond normal biological and analytical variation.^[7]

In practical terms, this means your creatinine rising from 0.9 to 1.2 mg/dL over six months — both values comfortably within the reference range of 0.7–1.3 — may actually be a more important signal than a single reading of 1.4 that comes back flagged as “high.” The first represents a 33% increase in your personal baseline. The second might be a dehydrated morning after a heavy training week.

Tucker et al. showed that self-monitoring of health data — even something as simple as blood pressure — is associated with improved outcomes.^[2] The act of tracking creates accountability, surfaces trends, and enables earlier intervention. The same principle applies to bloodwork: consistent, serial tracking reveals the trajectory that any single snapshot obscures.

The labs that matter most.

Not all lab panels are created equal. What you should be tracking depends on your goals, your medications, and your individual risk factors. Below are three monitoring panels organized by context. These are not exhaustive — your physician may add or subtract markers based on your clinical picture.

TRT Monitoring Panel

If you are on testosterone replacement therapy, the Endocrine Society recommends baseline labs and periodic reassessment of these markers.^[3] The AUA provides complementary guidance with similar monitoring recommendations.^[4]

GLP-1 Monitoring Panel

If you are on semaglutide, tirzepatide, or another GLP-1 receptor agonist, metabolic markers take center stage. Rapid weight loss can mask nutrient deficiencies and alter liver and kidney function tests.

General Health Panel

Whether or not you are on a protocol, these markers form the foundation of a comprehensive health picture. Most annual physicals will cover these, though many people never look beyond the “normal/abnormal” flag.

Reading your CBC.

The complete blood count is the most commonly ordered lab test in medicine, and most people have no idea what it contains. A CBC measures the cellular components of your blood: red blood cells (erythrocytes), white blood cells (leukocytes), and platelets (thrombocytes), along with derived values like hemoglobin concentration and hematocrit percentage.

Red blood cell markers

Hemoglobin (Hgb) measures the oxygen-carrying protein inside your red blood cells. Normal for men: roughly 13.5–17.5 g/dL; for women: 12.0–15.5 g/dL. Low hemoglobin is the textbook definition of anemia. High hemoglobin, particularly on TRT, often tracks with elevated hematocrit and carries similar viscosity concerns.

MCV (mean corpuscular volume) tells you the average size of your red blood cells. This is a diagnostic clue that most people skip. Low MCV (microcytic) suggests iron deficiency. High MCV (macrocytic) may indicate B12 or folate deficiency — both of which are relevant if you are on a GLP-1 agonist, which can impair B12 absorption. A CBC that shows “normal” hemoglobin with an elevated MCV is not normal — it is a red blood cell population that is compensating for a nutritional deficit.

White blood cell markers

Total WBC is a blunt instrument. Elevated WBC can reflect infection, inflammation, stress, or simply an intense training session the day before your draw. Chronically elevated WBC in the absence of obvious infection may be a marker of systemic inflammation — worth noting, but not actionable in isolation.

The differential — the breakdown into neutrophils, lymphocytes, monocytes, eosinophils, and basophils — is where the diagnostic value lives. A high neutrophil count suggests bacterial infection or acute stress. Elevated eosinophils may indicate allergies or parasitic infection. A persistently inverted neutrophil-to-lymphocyte ratio can be a marker of chronic stress or overtraining. Most lab reports print the differential. Most people ignore it.

Platelets

Platelet count is usually unremarkable for healthy individuals, but worth monitoring if you are on any medication that affects clotting or if your hematocrit is elevated. Normal range: 150,000–400,000/mcL. Very low platelets (thrombocytopenia) increase bleeding risk. Very high platelets (thrombocytosis) can increase clotting risk — relevant context if you already have thick blood from an elevated hematocrit.

Reading your metabolic panel.

The comprehensive metabolic panel (CMP) is a 14-marker panel that covers glucose, electrolytes, kidney function, and liver function. It is the other half of your annual bloodwork foundation, and it contains more actionable information than most people realize.

Glucose and metabolic markers

Fasting glucose is the headline number. Below 100 mg/dL is “normal.” But a fasting glucose of 95 mg/dL that was 78 mg/dL two years ago is telling you something — even though both values are within range. That 17-point rise, if it continues on the same trajectory, will cross the prediabetes threshold (100–125 mg/dL) within a few years. The trend was visible long before the flag appeared.

HbA1c is not part of a standard CMP but is often ordered alongside it. It reflects your average blood glucose over the preceding 2–3 months. Below 5.7% is normal. 5.7–6.4% is prediabetes. Above 6.5% is diabetes. For anyone on a GLP-1 agonist, HbA1c is the primary efficacy marker — the number that tells you whether the medication is doing its job.

Kidney function

Creatinine and BUN (blood urea nitrogen) are the kidney’s report card. Creatinine is a waste product from muscle metabolism, so it tends to run higher in muscular individuals — a fact that can cause false alarms. A creatinine of 1.3 mg/dL in a 200-pound lifter is not the same as a creatinine of 1.3 in a sedentary 140-pound person. Context matters.

eGFR (estimated glomerular filtration rate) is calculated from creatinine, age, sex, and (in some formulas) race. It estimates how efficiently your kidneys are filtering blood. Above 60 is generally considered adequate. Above 90 is normal. The formula was not designed for highly muscular individuals, so interpret with caution if you carry significant lean mass — your creatinine-based eGFR may underestimate your actual kidney function.

Liver function

ALT (alanine aminotransferase) and AST (aspartate aminotransferase) are liver enzymes that get flagged frequently in active individuals. Here is the nuance: AST is not liver-specific — it is also present in skeletal muscle, cardiac muscle, and red blood cells. A heavy leg session 48 hours before your blood draw can elevate AST without any liver pathology. ALT is more liver-specific but can also rise with intense exercise.

The clinical significance depends on the magnitude and pattern. Both enzymes mildly elevated (1.5–2x upper limit) after a hard training week? Probably exercise-induced. ALT persistently elevated at 3x or more? That warrants further investigation regardless of training status. If you are on any oral medication metabolized by the liver, including some oral testosterone formulations, monitoring liver enzymes is not optional.

The trend line is the signal.

Everything above leads to one central principle: your most important lab value is the one that changed. Not the one that is highest or lowest. Not the one flagged in red. The one that moved.

The reference change value methodology, as described by Petersen et al., provides a framework for determining when a change between two sequential measurements exceeds what can be explained by normal biological and analytical variation.^[7] For most common analytes, a change of more than 20–30% between draws in the same individual is likely clinically significant — even if both values fall within the population reference range.

This is why tracking matters. If you draw labs once, you get a snapshot. If you draw them twice, you get a direction. If you draw them three or more times, you get a trajectory — and trajectories are what allow early intervention. A fasting glucose drifting upward by 5 mg/dL per year is visible at year two, actionable at year three, and diagnosable as prediabetes at year five. The question is when you want to start paying attention.

• •Draw labs at least annually. Every 3–6 months if you are on any protocol that affects your bloodwork.
• •Use the same lab and the same draw conditions (fasting, time of day, hydration status) to minimize analytical noise.
• •Compare your current values to YOUR previous values, not to a population range.
• •Look for markers that have changed by more than 20% between draws — those warrant attention regardless of whether they are flagged.
• •Keep a running log. Spreadsheet, app, paper — the medium does not matter. The history does.

Ceriotti et al. confirmed that this approach — serial comparison against your own biological baseline — consistently outperforms single-point comparison against population norms for detecting early-stage metabolic changes, organ dysfunction, and treatment response.^[1]

When to worry vs. when to watch.

Not every abnormal result is a crisis, and not every “normal” result is reassuring. The clinical challenge — and the challenge for anyone trying to read their own labs intelligently — is knowing which category you are in.

Watch (monitor, do not panic)

• •A single value slightly outside the reference range, with no previous labs for comparison. Recheck in 4–8 weeks under the same conditions before drawing conclusions.
• •Mildly elevated AST/ALT (up to 2x upper limit) if you trained heavily in the 48–72 hours before the draw. Recheck after 5–7 days of rest.
• •Hematocrit in the 50–52% range on TRT, stable over multiple draws. Worth monitoring closely, but not an emergency if the trend is flat.
• •A low-normal value (e.g., vitamin D at 22 ng/mL, ferritin at 25 ng/mL) that is not causing symptoms. Optimize through diet or supplementation and recheck.
• •Mildly elevated creatinine in a muscular individual with normal eGFR and no other kidney markers flagged.

Worry (act now, consult your physician)

• •Any value more than 3x the upper limit of normal. This is outside the range where “it’s probably fine” applies.
• •Hematocrit above 54%, especially if rising. Immediate medical evaluation for thromboembolic risk.
• •Rapidly declining eGFR or rising creatinine over sequential draws. Kidney function does not repair easily — early intervention matters.
• •Fasting glucose above 126 mg/dL or HbA1c above 6.5% on a confirmed repeat test. These are diagnostic thresholds for diabetes.
• •Any lab value that is changing rapidly in a direction it should not be, even if both values are technically “within range.” A ferritin that doubled in six months, a TSH that tripled, or a platelet count that halved all warrant investigation.

References.

1. [1] Ceriotti F, Henny J, Queraltó J, et al. “Common reference intervals for aspartate aminotransferase (AST), alanine aminotransferase (ALT) and γ-glutamyl transferase (GGT) in serum: results from an IFCC multicenter study.” Clin Chem Lab Med. 2010;48(11):1593–1601.
2. [2] Tucker KL, Sheppard JP, Stevens R, et al. “Self-monitoring of blood pressure in hypertension: A systematic review and individual patient data meta-analysis.” BMJ. 2017;359:j5331.
3. [3] Bhasin S, et al. “Testosterone Therapy in Men With Hypogonadism: Endocrine Society Guideline.” J Clin Endocrinol Metab. 2018;103(5):1715–1744.
4. [4] Mulhall JP, et al. “Evaluation and Management of Testosterone Deficiency: AUA Guideline.” J Urol. 2018;200(2):423–432.
5. [5] Harman SM, et al. “Longitudinal Effects of Aging on Serum Testosterone Levels.” J Clin Endocrinol Metab. 2001;86(2):724–731.
6. [6] Nuttall FQ. “Body Mass Index: Obesity, BMI, and Health: A Critical Review.” Nutr Today. 2015;50(3):117–128.
7. [7] Petersen PH, Fraser CG, Sandberg S, Goldschmidt H. “The index of individuality is often a misinterpreted quantity characteristic.” Clin Chem Lab Med. 1999;37(6):655–661.